19
October
2020


Share on networks

Ypsomed,  a Swiss medical technology company specialized in the development and manufacture of injection and infusion systems for self-medication, will open a digital hub in Barcelona and create 40 jobs in the next two years. The company will centralize in Catalonia, together with the headquarters in Switzerland, the development of digital and connected devices to improve the treatment of chronic diseases such as diabetes, among others. According to ACCIÓ, there are currently more than 420 subsidiaries of Swiss companies established in Catalonia.

http://www.accio.gencat.cat/ca/accio/premsa-comunicacio/cercador-premsa-actualitat/article/10092020-Ypsomed

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.